Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitebtgplc.com
Phone+44 (0)20 7575 0000
Emailcustomerservice@b...
Employees
Descriptionpharmaceuticals company

Offices

HQ
5 Fleet Place
London, EC4M 7RD, GBR

People

general manager

Acquisitions

Total$462M
EKOS Corporation, 5/2013 $220M
Biocompatibles International, 11/2010 $242M

Investments

QuNano 5/2006

Tags

BTG

BTG is an international specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists, and is building a sustainable business financed by revenues from sales of its critical care products and from royalties and milestone payments on partnered products.

Recent Milestones

Videos

Screenshots

BTG screenshot
Above: BTG Screenshot -- #1
Uploaded: 11/10/10

Sources

  1. BTG to Buy EKOS, Maker of Clot-Removing Device, for Up To $220M (pevc.dowjones.com) [edit]
  2. BTG buys rival for $242M (fiercebiotech.com) [edit]
  3. QuNano AB Announces Closing of Series A Financing Round (qunano.com) [edit]
Edit This Page
Last Edited 3/28/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy